These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37112719)

  • 21. Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
    Ribadeau Dumas F; N'Diaye DS; Paireau J; Gautret P; Bourhy H; Le Pen C; Yazdanpanah Y
    Vaccine; 2015 May; 33(20):2367-78. PubMed ID: 25797366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to inTerrupt RAbies Transmission for the Elimination Goal by 2030 In China (STRATEGIC): a modelling study.
    Chen Q; Liu Q; Gong C; Yin W; Mu D; Li Y; Ding S; Liu Y; Yang H; Zhou S; Chen S; Tao Z; Zhang Y; Tang X
    BMC Med; 2023 Mar; 21(1):100. PubMed ID: 36927437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rabies epidemiology and control in India: a review.
    Acharya AS; Kaur R; Lakra K
    J Commun Dis; 2012 Jun; 44(2):59-69. PubMed ID: 25151750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developments in human rabies prophylaxis.
    Warrell MJ
    Rev Sci Tech; 2018 Aug; 37(2):629-647. PubMed ID: 30747121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost of rabies post exposure prophylaxis in different healthcare settings in six states of India.
    Haradanhalli RS; D Hanumanthaiah AN; Varadappa ST
    Indian J Public Health; 2019 Sep; 63(Supplement):S44-S47. PubMed ID: 31603091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling to inform prophylaxis regimens to prevent human rabies.
    Hampson K; Abela-Ridder B; Bharti O; Knopf L; Léchenne M; Mindekem R; Tarantola A; Zinsstag J; Trotter C
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A166-A173. PubMed ID: 30528846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis.
    LeGuerrier P; Pilon PA; Deshaies D; Allard R
    Vaccine; 1996 Feb; 14(2):167-76. PubMed ID: 8852415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How familiar are our doctors towards Rabies prophylaxis- A study from coastal south India.
    Holla R; Darshan B; Guliani A; Unnikrishnan B; Thapar R; Mithra P; Kumar N; Kulkarni V; Kumar A; Anwar S
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006032. PubMed ID: 29084226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a modified rabies immunoglobulin protocol in a crisis of unavailability: Ethical and practical challenges.
    Bharti OK
    Indian J Med Ethics; 2019; 4(2):139-143. PubMed ID: 31271357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An important date in rabies history.
    Dodet B;
    Vaccine; 2007 Dec; 25(52):8647-50. PubMed ID: 18037541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New human rabies vaccines in the pipeline.
    Fooks AR; Banyard AC; Ertl HCJ
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A140-A145. PubMed ID: 30153997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies in rabies vaccination.
    Ghosh TK
    Indian J Pediatr; 2003 Jun; 70(6):495-8. PubMed ID: 12921319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014.
    Tarantola A; Ly S; Chan M; In S; Peng Y; Hing C; Taing CN; Phoen C; Ly S; Cauchemez S; Buchy P; Dussart P; Bourhy H; Mary JY
    Vaccine; 2019 Oct; 37 Suppl 1():A118-A127. PubMed ID: 30454946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses.
    Yu PC; Dan M; He Y; Meng SL; Yang HY; Su X; Wang YJ; Lv L; Sun YF; Tao XY; Liu Q; Liu SQ; Bi SL; Zhu WY
    Microb Pathog; 2023 Dec; 185():106425. PubMed ID: 37923181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis.
    Kulkarni PS; Raut SK; Jadhav SS; Kapre SV; Deuskar N
    Hum Vaccin; 2007; 3(5):183-6. PubMed ID: 17637572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study.
    Kong LY; Vincelette J; Laplante G; Duchesne JA; Libman M; Barkati S
    CMAJ Open; 2018 Apr; 6(2):E168-E175. PubMed ID: 29636332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children.
    Chulasugandha P; Khawplod P; Havanond P; Wilde H
    Vaccine; 2006 Feb; 24(9):1478-82. PubMed ID: 16221511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country.
    Angsuwatcharakon P; Ratananpinit N; Yoksan S; Saengseesom W; Sriaksorn R; Raksahket N; Tantawichien T
    Vaccine; 2020 Jul; 38(32):5015-5020. PubMed ID: 32522414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India.
    Sudarshan MK; Ashwath Narayana DH
    Indian J Public Health; 2019 Sep; 63(Supplement):S51-S53. PubMed ID: 31603093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.